Akero Therapeutics
AKRO
AKRO
157 hedge funds and large institutions have $2.63B invested in Akero Therapeutics in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 156 → 157 (+1)
0.46% less ownership
Funds ownership: 102.34% → 101.88% (-0.46%)
32% less call options, than puts
Call options by funds: $40.8M | Put options by funds: $60.2M
Holders
157
Holding in Top 10
8
Calls
$40.8M
Puts
$60.2M
Top Buyers
| 1 | +$83.4M | |
| 2 | +$67.5M | |
| 3 | +$66.2M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$53.4M |
| 5 |
CC
Commodore Capital
New York
|
+$41.3M |
Top Sellers
| 1 | -$77M | |
| 2 | -$66.4M | |
| 3 | -$24.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.1M |